Main container

Analisi del profilo molecolare del mixofibrosarcoma delle estremità: impatto diagnostico e prognostico

Title
Analisi del profilo molecolare del mixofibrosarcoma delle estremità: impatto diagnostico e prognostico
Code
MFS
Type
Osservazionale
Start Year
2020
Status
Terminato

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Clinical Trial
A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors
Read more
Clinical Trial
Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors
Read more
Content updated
25/01/2023 09:41